Metformin Therapy for Improving Uterine Environment

Immediate Management and Contraception

The American College of Obstetricians and Gynecologists recommends continuing metformin at therapeutic doses (1.5-2g daily) for long-term metabolic and reproductive benefits, despite lack of immediate uterine effects 1, 2
Provide contraception counseling immediately, as metformin may restore ovulation unpredictably, potentially leading to unplanned pregnancy before optimal metabolic control is achieved 2, 3
The American College of Obstetricians and Gynecologists confirms that metformin is not first-line therapy for ovulation induction and should not be expected to improve fertility in the immediate cycle 4, 2

Plan for 3-6 months of metformin therapy before expecting maximal reproductive benefits, including improved endometrial receptivity and uterine blood flow 2
Consider clomiphene citrate or letrozole as first-line ovulation induction if pregnancy is desired urgently, as these achieve significantly higher pregnancy rates than metformin alone 2
Combine lifestyle modification, as even 5% weight loss enhances metformin's metabolic and reproductive effects 4, 2
Metformin crosses the placenta readily, with fetal levels equal to or higher than maternal levels 1, 2
Children exposed to metformin in utero demonstrate higher BMI, increased waist circumference, and increased obesity risk at ages 4-10 years 1, 2
The American College of Obstetricians and Gynecologists recommends against continuing metformin through the first trimester without careful consideration of emerging evidence of adverse offspring metabolic outcomes 2, 3

Renal impairment is a contraindication if eGFR <30 mL/min/1.73m² 3
Hepatic disease, alcohol abuse, or hypoxemic conditions are contraindications 1, 3
Acute illness with dehydration or hypoxemia requires temporary discontinuation of metformin 1